EP1841406A4 - Methods and formulations - Google Patents

Methods and formulations

Info

Publication number: EP1841406A4
Authority: EP; European Patent Office
Prior art keywords: formulations; methods
Prior art date: 2004-12-21
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.): Withdrawn

Application number

EP05854851A

Other languages

German (de)

French (fr)

Other versions

EP1841406A2 (en

Inventor

Simon M Blake

William Henry Miller

Amyn Sayani

H Jeffrey Wilkens

Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)

SmithKline Beecham Corp

Original Assignee

SmithKline Beecham Corp

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

2004-12-21

Filing date

2005-12-20

Publication date

2008-06-25

2005-12-20 Application filed by SmithKline Beecham Corp filed Critical SmithKline Beecham Corp

2007-10-10 Publication of EP1841406A2 publication Critical patent/EP1841406A2/en

2008-06-25 Publication of EP1841406A4 publication Critical patent/EP1841406A4/en

Status Withdrawn legal-status Critical Current

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
- A61K8/4906—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds with one nitrogen as the only hetero atom
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
- A61K9/0014—Skin, i.e. galenical aspects of topical compositions
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q19/00—Preparations for care of the skin
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/20—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing sulfur, e.g. dimethyl sulfoxide [DMSO], docusate, sodium lauryl sulfate or aminosulfonic acids

Landscapes

Health & Medical Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Dermatology (AREA)
Epidemiology (AREA)
Organic Chemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Birds (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicinal Preparation (AREA)

EP05854851A 2004-12-21 2005-12-20 Methods and formulations Withdrawn EP1841406A4 (en)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US63782404P	2004-12-21	2004-12-21
PCT/US2005/046204 WO2006069079A2 (en)	2004-12-21	2005-12-20	Methods and formulations

Publications (2)

Publication Number	Publication Date
EP1841406A2 EP1841406A2 (en)	2007-10-10
EP1841406A4 true EP1841406A4 (en)	2008-06-25

Family

ID=36602271

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
EP05854851A Withdrawn EP1841406A4 (en)	2004-12-21	2005-12-20	Methods and formulations

Country Status (6)

Country	Link
EP (1)	EP1841406A4 (en)
JP (1)	JP2008524334A (en)
AR (1)	AR052823A1 (en)
PE (1)	PE20060870A1 (en)
TW (1)	TW200635902A (en)
WO (1)	WO2006069079A2 (en)

Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1998014192A1 (en) *	1996-10-02	1998-04-09	Smithkline Beecham Corporation	Vitronectin receptor antagonists
WO2000033838A1 (en) *	1998-12-04	2000-06-15	Smithkline Beecham Corporation	Vitronectin receptor antagonist
WO2002083125A1 (en) *	2001-04-10	2002-10-24	Smithkline Beecham Corporation	Method of inhibiting adhesion formation

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO2000046215A1 (en) *	1999-02-03	2000-08-10	Merck & Co., Inc.	Benzazepine derivatives as alpha-v integrin receptor antagonists

2005
- 2005-12-20 WO PCT/US2005/046204 patent/WO2006069079A2/en active Application Filing
- 2005-12-20 EP EP05854851A patent/EP1841406A4/en not_active Withdrawn
- 2005-12-20 JP JP2007548398A patent/JP2008524334A/en not_active Withdrawn
- 2005-12-20 AR ARP050105363A patent/AR052823A1/en unknown
- 2005-12-20 TW TW094145347A patent/TW200635902A/en unknown
2006
- 2006-01-03 PE PE2006000024A patent/PE20060870A1/en not_active Application Discontinuation

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
WO1998014192A1 (en) *	1996-10-02	1998-04-09	Smithkline Beecham Corporation	Vitronectin receptor antagonists
WO2000033838A1 (en) *	1998-12-04	2000-06-15	Smithkline Beecham Corporation	Vitronectin receptor antagonist
WO2002083125A1 (en) *	2001-04-10	2002-10-24	Smithkline Beecham Corporation	Method of inhibiting adhesion formation

Also Published As

Publication number	Publication date
WO2006069079A2 (en)	2006-06-29
PE20060870A1 (en)	2006-08-16
WO2006069079A3 (en)	2007-04-19
EP1841406A2 (en)	2007-10-10
AR052823A1 (en)	2007-04-04
TW200635902A (en)	2006-10-16
JP2008524334A (en)	2008-07-10

Publication	Publication Date	Title
GB0422525D0 (en)	2004-11-10	Dermatological compositions and methods
IL209494A (en)	2015-07-30	Insulin-oligomer monoconjugates, formulations and uses thereof
EP1802588A4 (en)	2010-02-17	Substituted amino-pyrimidones and uses thereof
GB0414825D0 (en)	2004-08-04	Gel formulations and uses thereof
IL181670A0 (en)	2007-07-04	Substituted phenylaminothiazoles and use thereof
EP1819226A4 (en)	2010-12-29	Immunostimulatory combinations and methods
HK1101911A1 (en)	2007-11-02	Tetrahydrocarbozoles and derivatives
GB0411940D0 (en)	2004-06-30	Methods and compositions
EP1701725A4 (en)	2009-07-01	Methods and compositions
IL191072A0 (en)	2008-12-29	Therapeutic compositions and methods
IL179497A0 (en)	2011-08-01	Carboranylporphyrins and uses thereof
IL178888A0 (en)	2007-03-08	Arylphenylamino-, arylphenylamide-, and arylphenylether-sulfide derivatives
EP1841397A4 (en)	2010-01-27	Formulations and treatments for trichology
EP1737565A4 (en)	2010-11-03	Cos-claus configurations and methods
IL184062A0 (en)	2007-10-31	Visco-supplement composition and methods
ZA200706128B (en)	2008-12-31	Pesticide compositions and methods
IL180365A0 (en)	2007-06-03	Carboranylporphyrins and uses thereof
IL181300A0 (en)	2008-04-13	Photosensitizer formulations and uses thereof
EP1807071A4 (en)	2008-01-09	Antipyretic compositions and methods
EP1838163A4 (en)	2011-07-20	Dairy ingredient - preparation and use
PL2215908T3 (en)	2012-03-30	2-Alkyl-cycloalk(en)yl-carboxamides and their use as fungizides
GB0424552D0 (en)	2004-12-08	Methods and means
GB0403847D0 (en)	2004-03-24	Methods and means
ZA200706038B (en)	2008-12-31	Visco-supplement composition and methods
EP1810976A4 (en)	2007-10-17	Benzonaphthaceneglycoside derivative and use thereof

Legal Events

Date	Code	Title	Description
2007-09-07	PUAI	Public reference made under article 153(3) epc to a published international application that has entered the european phase	Free format text: ORIGINAL CODE: 0009012
2007-10-10	17P	Request for examination filed	Effective date: 20070718
2007-10-10	AK	Designated contracting states	Kind code of ref document: A2 Designated state(s): AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HU IE IS IT LI LT LU LV MC NL PL PT RO SE SI SK TR
2007-10-10	AX	Request for extension of the european patent	Extension state: AL BA HR MK YU
2007-12-12	RIC1	Information provided on ipc code assigned before grant	Ipc: A01N 25/00 20060101ALI20071108BHEP Ipc: A01N 65/00 20060101AFI20071108BHEP
2008-03-26	RAX	Requested extension states of the european patent have changed	Extension state: HR Payment date: 20070718
2008-06-25	A4	Supplementary search report drawn up and despatched	Effective date: 20080526
2008-08-20	17Q	First examination report despatched	Effective date: 20080721
2009-04-24	STAA	Information on the status of an ep patent application or granted ep patent	Free format text: STATUS: THE APPLICATION IS DEEMED TO BE WITHDRAWN
2009-05-27	18D	Application deemed to be withdrawn	Effective date: 20081202